PARCHI, PIERO
 Distribuzione geografica
Continente #
NA - Nord America 9.806
EU - Europa 6.938
AS - Asia 3.595
AF - Africa 280
SA - Sud America 25
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 2
Totale 20.659
Nazione #
US - Stati Uniti d'America 9.773
GB - Regno Unito 2.198
IT - Italia 1.425
CN - Cina 1.152
DE - Germania 980
VN - Vietnam 944
SG - Singapore 902
SE - Svezia 647
UA - Ucraina 425
IN - India 383
IE - Irlanda 318
FR - Francia 277
RU - Federazione Russa 213
EE - Estonia 137
ZA - Sudafrica 134
JO - Giordania 72
FI - Finlandia 65
CI - Costa d'Avorio 59
BG - Bulgaria 57
ID - Indonesia 53
CH - Svizzera 44
TG - Togo 41
NL - Olanda 35
CA - Canada 30
JP - Giappone 30
BE - Belgio 28
SC - Seychelles 28
AT - Austria 22
BR - Brasile 22
GR - Grecia 17
NG - Nigeria 14
ES - Italia 13
HK - Hong Kong 11
LB - Libano 11
AU - Australia 10
IR - Iran 9
UZ - Uzbekistan 9
DK - Danimarca 8
PL - Polonia 7
HU - Ungheria 5
TR - Turchia 5
CZ - Repubblica Ceca 4
KR - Corea 4
PT - Portogallo 4
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
RO - Romania 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BZ - Belize 2
IL - Israele 2
PH - Filippine 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CO - Colombia 1
EG - Egitto 1
HR - Croazia 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 20.659
Città #
Southend 1.986
Fairfield 1.227
Chandler 795
Singapore 795
Ashburn 770
Woodbridge 613
Houston 602
Seattle 587
Dong Ket 580
Wilmington 548
Ann Arbor 522
Cambridge 466
Princeton 424
Dublin 318
Bologna 312
Boardman 269
Jacksonville 265
Nanjing 173
Westminster 171
Berlin 154
Santa Clara 151
Padova 138
Redmond 134
Turin 119
Florence 94
Jinan 85
San Diego 82
Milan 80
Shenyang 80
Amman 72
Saint Petersburg 65
Beijing 64
Abidjan 59
Sofia 56
Medford 55
Changsha 54
Des Moines 53
Hebei 52
Nanchang 52
Jakarta 51
Mülheim 49
Tianjin 45
Guangzhou 42
Falls Church 41
Lomé 41
New York 40
Helsinki 39
Olalla 39
Imola 37
Verona 33
Dearborn 30
Shanghai 30
Brussels 28
Jiaxing 28
Bern 27
Los Angeles 27
Lappeenranta 26
Mahé 26
Norwalk 24
Redwood City 23
Zhengzhou 23
Hangzhou 22
London 22
Rome 22
Taiyuan 22
Boydton 20
Bühl 20
Haikou 19
Fuzhou 17
Vienna 17
Mountain View 16
Amsterdam 15
Ningbo 15
Tokyo 15
Toronto 14
Como 13
Lanzhou 13
Chicago 12
Garbagnate Milanese 12
Kuban 12
Phoenix 12
Taizhou 12
Bergamo 11
Wuhan 11
Abeokuta 10
Dallas 9
Harbin 9
Kunming 9
Nagasaki 9
Qingdao 9
Suzhou 9
Udine 9
Bremen 8
Forlì 8
Genoa 8
Hounslow 8
Shijiazhuang 8
Chengdu 7
Copenhagen 7
Frankfurt Am Main 7
Totale 14.369
Nome #
Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects. 460
The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population 224
Anterior Callosal Angle: A New Marker of Idiopathic Normal Pressure Hydrocephalus? 205
Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy 201
Abnormal ADC in the brain of prion disease patients: variation between brain structures. 188
A case of fatal familial insomnia in Africa. 182
A CTNNA3 compound heterozygous deletion implicates a role for αT-catenin in susceptibility to autism spectrum disorder. 178
Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain 1 H-MRS and volumetric changes: A two- year retrospective follow-up study 177
Analysis of Conformational Stability of Abnormal Prion Protein Aggregates across the Spectrum of Creutzfeldt-Jakob Disease Prions 167
Age at onset in genetic prion disease and the design of preventive clinical trials 162
"Agrypnia excitata'' in a case of sporadic Creutzfeldt-Jakob disease VV2 161
Messenger RNA processing is altered in autosomal dominant leukodystrophy 157
ADC and Proton Spectroscopy Reflect Cellular Pathology in Patients with Creutzfeldt-Jakob Disease 155
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease 154
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 151
Age at onset of genetic (E200K) and sporadic Creutzfeldt-Jakob diseases is modulated by theCYP4X1gene 151
An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene. 149
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 149
Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature 147
Maternally inherited genetic variants of CADPS2 are present in Autism Spectrum Disorders and Intellectual Disability patients. 146
A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study 142
An in vivo proton magnetic resonance spectroscopy study of thalamus in prion disease 141
Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: A single-center study 138
The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance 137
Clinical Reasoning: Rapidly progressive dementia in a patient with HIV after an exotic journey 137
A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient. 136
Muscle ceroid lipofuscin-like deposits in a patient with corticobasal syndrome due to a progranulin mutation 135
La risonanza magnetica di diffusione differenzia la degenerazione corticobasale dalla paralisi sopranucleare progressiva e dalla malattia di Parkinson. 134
Analyses of Protease Resistance and Aggregation State of Abnormal Prion Protein across the Spectrum of Human Prions 131
Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. 131
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A$\upbeta$42 levels 131
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 128
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing 127
Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. 126
Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases 126
Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants 125
Narcolepsy is a common phenotype in HSAN IE and ADCA-DN 125
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 125
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. 124
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins 124
Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1 124
Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. 123
Agrypnia Excitata 123
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 120
Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. 119
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias 119
A novel seven-octapeptide repeat insertion in the prion protein gene (PRNP) in a Dutch pedigree with Gerstmann-Straussler-Scheinker disease phenotype: comparison with similar cases from the literature. 118
Variably protease-sensitive prionopathy presenting within ALS/FTD spectrum 117
Pearls & Oy-sters: rapidly progressive dementia: prions or immunomediated? 116
Transmission properties of atypical Creutzfeldt-Jakob disease: A clue to disease etiology? 116
A refined method for molecular typing reveals that co-occurrence of PrP(Sc) types in Creutzfeldt-Jakob disease is not the rule. 116
Reduced in Vivo thalamic N-Acetyl-Aspartate is a Diagnostic Marker of Prion Disease 115
History and state of the art of PrP-res “typing” in Creutzfeldt-Jakob disease 115
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrP(Sc) types: an updated classification. 115
Brain banks: benefits, limitations and cautions concerning the use of post-mortem brain tissue for molecular studies. 115
Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings 115
Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges 114
Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis 114
Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies 113
Rapidly Progressive Alzheimer’s Disease: Contributions to Clinical-Pathological Definition and Diagnosis 113
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease 113
Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type) 110
Sporadic Creutzfeldt-Jakob Disease. 109
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium. 109
Creutzfeldt-Jakob disease with E200K PRNP mutation: a case report and revision of the literature 109
Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. 109
Clinicopathological features of the rare form of Creutzfeldt-Jakob disease in R208H-V129V PRNP carrier 109
Atypical neuropathological sCJD-MM phenotype with abundant white matter Kuru-type plaques sparing the cerebellar cortex. 108
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 108
MV2 subtype of sporadic Creutzfeldt-Jakob disease presenting as corticobasal syndrome 107
Effects of Formalin Fixation, Paraffin Embedding, and Time of Storage on DNA Preservation in Brain Tissue: A BrainNet Europe Study 106
Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium. 106
Inter-laboratory assessment of PrPSc typing in creutzfeldt-jakob disease: a Western blot study within the NeuroPrion Consortium. 106
Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions. 106
Patient with rapidly evolving neurological disease with neuropathological lesions of Creutzfeldt-Jakob disease, Lewy body dementia, chronic subcortical vascular encephalopathy and meningothelial meningioma 106
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 106
Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. 105
SPORADIC FATAL INSOMNIA IN A FATAL FAMILIAL INSOMNIA PEDIGREE 104
Cathepsin D (C224T) Polymorphism in Sporadic and Genetic Creutzfeldt-Jakob Disease 104
Inherited Creutzfeldt-Jakob disease in a Dutch patient with a novel five octapeptide repeat insertion and unusual cerebellar morphology. 104
PROTEIN AMYLOIDOSIS ASSOCIATED WITH A NOVEL STOP CODON MUTATION IN PRNP 103
Quantifying prion disease penetrance using large population control cohorts 103
null 103
Regional pattern of microgliosis in sporadic Creutzfeldt-Jakob disease in relation to phenotypic variants and disease progression 103
Mixed Brain Pathologies in Dementia: The BrainNet Europe Consortium Experience. 103
Heterogeneity of truncated fragments distinct from PrP27-30 correlates with clinico-pathological subtypes of Creutzfeldt-Jakob disease 102
Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: Insights into phenotypic variability and disease pathogenesis. 102
Cerebrospinal fluid real-time quaking-induced conversion is a robust and reliable test for sporadic creutzfeldt–jakob disease: An international study 102
Use of in vivo proton magnetic resonance spectroscopy in the differential diagnosis of prion diseases 101
Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease 101
Analysis of polymorphisms in PRNP 5' UTR region in sCJD subtypres 100
Genetic Creutzfeldt-Jakob Disease. 100
Iodine-123-meta-iodobenzylguanidine myocardial scintigraphy in isolated autonomic failure: Potential red flag for future multiple system atrophy 100
Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. 100
PrP conformational transitions alter species preference of a PrP-specific antibody. 99
Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. 99
Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study 99
Prion disease: an in vivo proton magnetic resonance spectroscopy study of thalamus. 98
An update of the epidemiology of sporadic Creutzfeldt-Jakob disease in Italy based on neuropathologic and molecular typing of a large cohort of patients 98
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study 98
Totale 12.785
Categoria #
all - tutte 58.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.282


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.132 0 0 0 0 514 513 645 713 794 380 278 295
2020/20213.326 545 218 93 144 99 174 127 241 306 173 135 1.071
2021/20223.709 348 137 248 179 347 209 86 354 177 309 729 586
2022/20233.875 430 489 161 486 285 284 142 217 679 100 392 210
2023/20241.224 74 185 109 132 131 142 54 112 47 103 75 60
2024/20252.138 207 793 376 361 401 0 0 0 0 0 0 0
Totale 21.231